PRT for Adolescents With High Functioning Autism
Pivotal Response Treatment for Adolescents With High Functioning Autism Intervention Study
1 other identifier
interventional
76
1 country
1
Brief Summary
The purpose of this study is to identify improvement in behavioral and social function and changes in the brain following Pivotal Response Treatment (PRT) for Adolescents in highly verbal adolescents with autism spectrum disorder (ASD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
March 28, 2024
March 1, 2024
3 years
March 10, 2023
March 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
(Target) Change from baseline (Pre-training) in brain connectivity between superior temporal sulcus (STS) and the nucleus accumbens (NAc)
Target engagement consists of brain connectivity between voice selective superior temporal sulcus (STS) and the nucleus accumbens (NAc) of the mesolimbic reward system. For the PRT (i.e., intervention) group, brain connectivity will be measured using the generalized psychophysiological interaction (gPPI) model, a common measure of task-based brain connectivity using fMRI data. gPPI betas from individual subject contrast maps will be computed using the STS as a seed region and the NAc as the connectivity target region. Effect size will be computed using Cohen's d for a paired t-test comparing Post-Training and Pre-Training pSTS-NAc connectivity values (i.e., contrast betas): d = t/(sqrt(n) where t is the paired t-test and n the group size.
Pre-treatment baseline, and between 11 to 13 weeks post-baseline
Change from baseline (Pre-training) in structured laboratory observations (SLO) of child-assessor interactions
The Structured Laboratory Observations (SLO) of child-assessor interactions is a common behavioral measure of each participant's social communicative interactions assessed in a laboratory setting. The metric used to characterize the SLO is an overall percentage of appropriate social responsiveness. Change in baseline SLO will be computed by subtracting Post- from Pre-training percentage of appropriate social responsiveness for each participant in the PRT group.
Pre-treatment baseline, and between 11 to 13 weeks post-baseline
Secondary Outcomes (6)
Change in the Social Communication subscale of the Brief Observation of Social Communication Change (BOSCC)
Pre-treatment baseline, and between 11 to 13 weeks post-baseline
(Secondary target) Change in brain connectivity between superior temporal sulcus (STS) and temporoparietal junction (TPJ)
Pre-treatment baseline, and between 11 to 13 weeks post-baseline
Association between change in target engagement and change in clinical benefit (STS and NAc)
Pre-treatment baseline, and between 11 to 13 weeks post-baseline
Association between change in target engagement and change in clinical benefit (STS and TPJ)
Pre-treatment baseline, and between 11 to 13 weeks post-baseline
Group differences in the association between change in target engagement and clinical benefit (STS and NAc)
Pre-treatment baseline, and between 11 to 13 weeks post-baseline
- +1 more secondary outcomes
Study Arms (2)
PRT Treatment Group
EXPERIMENTALAfter study participants have completed screenings to meet our inclusion criteria, participants will take part in the pre-intervention MRI brain scan and behavioral assessments and will then be assigned randomly to one of two arms of intervention for 9 weeks. Participants in the PRT Treatment Group will complete an 9-week intervention, PRT for Adolescents, to improve the adolescent's social skills. Following the completion of the 9-week intervention, participants will be asked to complete a second MRI brain imaging session, followed by post-measure appointments in order to assess immediate effects of the intervention.
Delayed Treatment Group
EXPERIMENTALAfter study participants have completed screenings to meet our inclusion criteria, participants will take part in the pre-intervention MRI brain scan and behavioral assessments and will then be assigned randomly to one of two arms of intervention for 9 weeks. After 9-weeks without any intervention, participants in the Delayed Treatment Group will be asked to complete a second MRI brain imaging session, followed by post-measure appointments, and will then receive the PRT intervention at the end of the study.
Interventions
Clinician-led 70-minute PRT sessions targeting social skills once per week at Stanford.
Eligibility Criteria
You may qualify if:
- Clinical Diagnosis of Autism Spectrum Disorder, higher functioning/low support needs
- Intelligence Quotient (IQ): Participants with a Full Scale IQ \> 80 on the Wechsler Abbreviated Scale of Intelligence (WASI-II)
- Right-handed
- No metal in their body/unremovable metal on their body (i.e., braces)
- First language is English
- Must live in the San Francisco Bay Area
- Able and willing to receive intervention weekly for 9 weeks
- Adolescent is interested in improving their social skills
- MRI Compatibility: No major contraindication for MRI.
- Diagnosis of ASD using ADOS-2 and ADI-R.
- No evidence of a genetic, metabolic, or infectious etiology for their autism.
- Primary diagnosis of ASD
- No evidence of significant difficulty during pregnancy, labor, delivery, or immediate neonatal period.
- Stable treatment (e.g., ABA), speech therapy, school placement, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation.
- Score of at least 50% or below on at least 4 out of the 9 social target areas in the SLO (administered during pre-measures)
- +1 more criteria
You may not qualify if:
- History of claustrophobia, previous head injury, serious neurological or medical illness, birth weight less than 4 lb. and/or gestational age \< 34 weeks
- Left-handed
- Braces or any metal in their body
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Research Park
Palo Alto, California, 94304, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dani A Abrams, Ph.D.
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
March 10, 2023
First Posted
August 14, 2023
Study Start
September 1, 2023
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
August 31, 2026
Last Updated
March 28, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share